Similarly, the α chain of IL-2RA encodes the IL-2 receptor, whose overexpression is closely associated with chemoresistance and poor prognosis in AML, and it has been shown that IL-2RA antibodies target leukemic cells without affecting normal hematopoietic cells. This evidence concerns the gene IL2RA and acute myeloid leukemia.